Hyperglycemic action of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride in relation to its hypertensive effect.
D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D001794:Blood Pressure / Q000187:drug effects*; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D001786:Blood Glucose; D006584:Hexamethonium Compounds; D007093:Imidazoles; D003983:Dibenzylchlorethamine; D012110:Reserpine; D011433:Propranolol; D004878:Ergotamine